CAP Software Now Available With XL Probe for Steatosis Measurement! FibroScan is capable of diagnosing both fibrosis and steatosis in the liver. However, the steatosis measurement (via CAP: controlled attenuation parameter) was only possible with the M probe for medium-sized patients. Technological advancements have now made it possible for the XL probe to measure steatosis as well. Contact KNS Canada if you are interested in purchasing CAP software.
You can read more about this update on the latest Echosens Clinical Newsletter.